共 8 条
[1]
IL-17 Expression in Dermatitis Herpetiformis and Bullous Pemphigoid.[J].Agnieszka Zebrowska;Malgorzata Wagrowska-Danilewicz;Marian Danilewicz;Olga Stasikowska-Kanicka;Anna Cynkier;Anna Sysa-Jedrzejowska;Elzbieta Waszczykowska;Alex Kleinjan.<journal-title>Mediators of Inflammation.2013,
[2]
LY2439821; a humanized anti–interleukin‐17 monoclonal antibody; in the treatment of patients with rheumatoid arthritis: A phase I randomized; double‐blind; placebo‐controlled; proof‐of‐concept study.[J].M. C.Genovese;F.Van den Bosch;S. A.Roberson;S.Bojin;I. M.Biagini;PeterRyan;J.Sloan‐Lancaster.Arthritis & Rheumatism.2010, 4
[4]
Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid.[J].Siavash Toosi;Jean-Claude Bystryn.Medical Hypotheses.2009, 4
[8]
Frequency analysis of autoreactive T‐helper 1 and 2 cells in bullous pemphigoid and pemphigus vulgaris by enzyme‐linked immunospot assay.[J].R.Eming;L.Büdinger;R.Riechers;O.Christensen;H.Bohlen;R.Kalish;M.Hertl.British Journal of Dermatology.2001, 6

